A Review on The Causative Agents, Risk Factors and Management of Ventilator-Associated Pneumonia: South Asian Perspective

Authors

  • Akash Ahmed Microbiology Program, Department of Mathematics & Natural Sciences, BRAC University, Dhaka, Bangladesh
  • Nahian Sanjida Naboni Microbiology Program, Department of Mathematics & Natural Sciences, BRAC University, Dhaka, Bangladesh
  • Afia Nowshen Biotechnology Program, Department of Mathematics & Natural Sciences, BRAC University, Dhaka, Bangladesh
  • Sadia Sultana Medical Epidemiologist, Institute of Epidemiology, Disease Control And Research, Dhaka, Bangladesh
  • Fahim Haque Microbiology Program, Department of Mathematics & Natural Sciences, BRAC University, Dhaka, Bangladesh
  • M Mahboob Hossain Microbiology Program, Department of Mathematics & Natural Sciences, BRAC University, Dhaka, Bangladesh

DOI:

https://doi.org/10.3329/jom.v23i2.60633

Keywords:

Ventilator-Associated Pneumonia; indwelling mechanical ventilation; endotracheal aspirates; antibiotic susceptibility; antibiotic therapy

Abstract

Ventilator-Associated Pneumonia (VAP) is common hospital-acquired pneumonia in ICU patients. Patients with pneumonia after 48 hours of mechanical ventilation are VAP affected. INICC found that VAP rates between 2012 to 2017 are 14.1 per 1000 episodes. The most common pathogens include Acinetobacter baumannii, Pseudomonas Aeruginosa and Klebsiella pneumoniae. Developing countries seem to have a higher mortality rate compared to developed countries. Treatment protocol involves antibiotic therapy. For the early onset of VAP, cephalosporin (cefotaxime or ceftriaxone), fluoroquinolone, or piperacillin-tazobactam are found to be effective while for late-onset, ceftazidime, ciprofloxacin, meropenem, and piperacillin-tazobactam seems to have positive Results. Apart from antibiotics, other options like bacteriophage therapy can offer a good alternative to fight the rapid emergence of MDR pathogens.

J MEDICINE 2022; 23: 151-161

Downloads

Download data is not yet available.

Downloads

Published

2022-07-24

How to Cite

Ahmed, A. ., Naboni, N. S. ., Nowshen, A. ., Sultana, S. ., Haque, F. ., & Hossain, M. M. . (2022). A Review on The Causative Agents, Risk Factors and Management of Ventilator-Associated Pneumonia: South Asian Perspective. Journal of Medicine, 23(2), 151–161. https://doi.org/10.3329/jom.v23i2.60633

Issue

Vol. 23 No. 2 (2022)

Section

Review Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).